Medicare Enrolled

Dr. Ashok Patel, M.D.

Optician · Toms River, NJ
Speaking/Promotional
20 HOSPITAL DR, Toms River, NJ 08755
7322442299
In practice since 2006 (19 years)
NPI: 1093809576 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Ashok Patel is an optician specialist in Toms River, NJ, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Patel received a total of $57,362 from 26 pharmaceutical and/or device companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $57,362 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$57,362
Total received (2018-2024)
Avg $8,195/year across 7 years
Top 4% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
327
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43,668 (76.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,731 (18.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,964 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,724
2023
$14,561
2022
$6,054
2021
$7,553
2020
$2,970
2019
$2,320
2018
$1,180

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$17,685
Eisai Inc.
$4,810
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Otsuka Pharmaceutical Development & Commercialization, Inc.
$64
ABBVIE INC.
$34
Lilly USA, LLC
$21
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$37,639
AbbVie Inc.
$7,500
Eisai Inc.
$4,916
Allergan, Inc.
$2,823
Allergan Inc.
$2,265
ABBVIE INC.
$351
ACADIA Pharmaceuticals Inc
$273
Takeda Pharmaceuticals U.S.A., Inc.
$269
Neurocrine Biosciences, Inc.
$176
Sunovion Pharmaceuticals Inc.
$150
Lundbeck LLC
$135
Avanir Pharmaceuticals, Inc.
$130
Otsuka Pharmaceutical Development & Commercialization, Inc.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Vanda Pharmaceuticals Inc.
$92
Shire North American Group Inc
$83
Lilly USA, LLC
$70
Teva Pharmaceuticals USA, Inc.
$64
PFIZER INC.
$63
Janssen Pharmaceuticals, Inc
$42
Jazz Pharmaceuticals Inc.
$39
Biohaven Pharmaceutical Holding Company Ltd.
$29
UCB, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme Corporation
$14
Bausch Health US, LLC
$14
Top 3 companies account for 87.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AMYVID · AUSTEDO · BELSOMRA · Briviact · CHANTIX · Dayvigo · Fanapt · Hetlioz · INGREZZA · LATUDA · Leqembi · MYDAYIS · NUEDEXTA · NUPLAZID · NURTEC ODT · QULIPTA · REXULTI · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · UBRELVY · VRAYLAR · VYVANSE · WELLBUTRIN XL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for optician in NJ.

Looking for an optician specialist in Toms River?
Compare opticians in the Toms River area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
288
Per 100K population
44.6
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is an optician specialist, with speaking/promotional industry engagement in the top 4% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $57,362 from 26 companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →